Epidemiology of respiratory syncytial virus in hospitalized children over a 9-year period and preventive strategy impact

被引:5
作者
Lodi, Lorenzo [1 ,2 ]
Catamero, Francesco [1 ]
Voarino, Marta [1 ]
Barbati, Federica [2 ,3 ]
Moriondo, Maria [4 ]
Nieddu, Francesco [4 ]
Sarli, Walter Maria [2 ]
Citera, Francesco [4 ]
Astorino, Valeria [4 ]
Pelosi, Caterina [4 ]
Quaranta, Francesca [4 ]
Stocco, Silvia [1 ]
Canessa, Clementina [2 ]
Lastrucci, Vieri [5 ]
Ricci, Silvia [1 ,2 ]
Indolfi, Giuseppe [6 ,7 ]
Azzari, Chiara [1 ,2 ]
机构
[1] Univ Florence, Dept Hlth Sci, Florence, Italy
[2] Meyer Childrens Hosp IRCCS, Dept Pediat Oncol, Neurooncol Unit, Florence, Italy
[3] St Stefano Hosp, AUSL Toscana Ctr, Pediat & Neonatol Unit, Prato, Italy
[4] Meyer Childrens Hosp IRCCS, Neurosci Dept, Florence, Italy
[5] Meyer Childrens Hosp IRCCS, Pediat Unit, Florence, Italy
[6] Univ Florence, Dept Neurofarba, Florence, Italy
[7] Meyer Childrens Hosp IRCCS, Dept Pediat, Liver Unit, Florence, Italy
关键词
respiratory syncytial virus; RSV; nirsevimab; prevention; children; bronchiolitis; SARS-CoV-2; RSV; PALIVIZUMAB; NIRSEVIMAB; INFECTION; PRETERM; INFANTS; YOUNGER; BURDEN;
D O I
10.3389/fphar.2024.1381107
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Respiratory Syncytial Virus (RSV) is the primary cause of respiratory infections and hospitalizations in young children globally, leading to substantial disease burden and mortality. The aim of the present study was to review and provide updates on how the SARS-CoV-2 pandemic have significantly influenced RSV epidemiology on hospitalized children due to RSV infection. A potential impact of the available preventive strategies on the same population were provided.Methods: All children aged 0-6 years hospitalized at Meyer Children's Hospital IRCCS for RSV infection from September 2014 to March 2023 were retrospectively recorded. Seasonal trends before and after SARS-CoV-2 pandemic, age distribution, ICU admission and co-infections, comorbidities and prematurity were retrieved. Predictions on the number of hospitalizations avoided by the deployment of different preventive strategies were provided.Results: A total of 1,262 children with RSV infection were included in the study. The 70% of them had less than 1 year-of-age at the moment of hospitalization and almost 50% less than 3 months. In the post-pandemic seasons, a 317% increase in the number of hospitalizations was recorded with a significant increase in older children compared to the pre-pandemic seasons. ICU support was required for 22% of children, the majority of whom were under 3 months of age. Almost 16% of hospitalized children were born preterm and only 27% of hospitalized children had prior comorbidities. The rate of comorbidities among RSV hospitalized children increased with age. Nirsevimab prophylaxis could have prevented more than 46% of hospitalizations in this cohort. A preventive strategy addressing also children aged 7 months to 6 years of age with co-existing comorbidities would increase that rate above 57%.Discussion: The identification of RSV hospitalization-related features is informing the decision-maker for the deployment of the wisest preventive approach on a population scale.
引用
收藏
页数:8
相关论文
共 21 条
  • [1] Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
    Azzari, Chiara
    Baraldi, Eugenio
    Bonanni, Paolo
    Bozzola, Elena
    Coscia, Alessandra
    Lanari, Marcello
    Manzoni, Paolo
    Mazzone, Teresa
    Sandri, Fabrizio
    Lisi, Giovanni Checcucci
    Parisi, Salvatore
    Piacentini, Giorgio
    Mosca, Fabio
    [J]. ITALIAN JOURNAL OF PEDIATRICS, 2021, 47 (01)
  • [2] Epidemiology of Respiratory Syncytial Virus-Related Hospitalization Over a 5-Year Period in Italy: Evaluation of Seasonality and Age Distribution Before Vaccine Introduction
    Barbati, Federica
    Moriondo, Maria
    Pisano, Laura
    Calistri, Elisa
    Lodi, Lorenzo
    Ricci, Silvia
    Giovannini, Mattia
    Canessa, Clementina
    Indolfi, Giuseppe
    Azzari, Chiara
    [J]. VACCINES, 2020, 8 (01)
  • [3] Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries
    Bont L.
    Checchia P.A.
    Fauroux B.
    Figueras-Aloy J.
    Manzoni P.
    Paes B.
    Simões E.A.F.
    Carbonell-Estrany X.
    [J]. Infectious Diseases and Therapy, 2016, 5 (3) : 271 - 298
  • [4] Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity
    Domachowske, Joseph
    Madhi, Shabir A.
    Simoes, Eric A. F.
    Atanasova, Victoria
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (09) : 892 - 894
  • [5] Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
    Griffin, M. Pamela
    Yuan, Yuan
    Takas, Therese
    Domachowske, Joseph B.
    Madhi, Shabir A.
    Manzoni, Paolo
    Simoes, Eric A. F.
    Esser, Mark T.
    Khan, Anis A.
    Dubovsky, Filip
    Villafana, Tonya
    DeVincenzo, John P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) : 415 - 425
  • [6] Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
    Hammitt, Laura L.
    Dagan, Ron
    Yuan, Yuan
    Cots, Manuel Baca
    Bosheva, Miroslava
    Madhi, Shabir A.
    Muller, William J.
    Zar, Heather J.
    Brooks, Dennis
    Grenham, Amy
    Hamren, Ulrika Wahlby
    Mankad, Vaishali S.
    Ren, Pin
    Takas, Therese
    Abram, Michael E.
    Leach, Amanda
    Griffin, M. Pamela
    Villafana, Tonya
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (09) : 837 - 846
  • [7] Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study
    Henderson, J
    Hilliard, TN
    Sherriff, A
    Stalker, D
    Shammari, NA
    Thomas, HM
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2005, 16 (05) : 386 - 392
  • [8] Three monthly doses of palivizumab are not adequate for 5-month protection: A population pharmacokinetic analysis
    La Via, William V.
    Notario, Gerard F.
    Yu, Xiang-Qing
    Sharma, Shringi
    Noertersheuser, Peter A.
    Robbie, Gabriel J.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2013, 26 (06) : 666 - 671
  • [9] The role of viral co-infections in the severity of acute respiratory infections among children infected with respiratory syncytial virus (RSV): A systematic review and meta-analysis
    Li, You
    Pillai, Pallavi
    Miyake, Fuyu
    Nair, Harish
    [J]. JOURNAL OF GLOBAL HEALTH, 2020, 10 (01)
  • [10] Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023
    Martinon-Torres, Federico
    Miras-Carballals, Susana
    Duran-Parrondos, Carmen
    [J]. EUROSURVEILLANCE, 2023, 28 (49)